Live Breaking News & Updates on Therapeutic Target

Stay updated with breaking news from Therapeutic target. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

PKMYT1, a potential 'Achilles heel' of treatment resistant ER+ breast cancers with the poorest prognosis

PKMYT1, a potential 'Achilles heel' of treatment resistant ER+ breast cancers with the poorest prognosis
medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.

Charles Foulds , Yanran Chen , Drug Administration , Baylor College Of Medicine , Molecular Cancer Therapeutics , Baylor College , Molecular Cancer , Treatment Response , Therapeutic Target , Breast Cancer ,

Alector to Host Two Virtual Research and Development Events Highlighting TREM2 and Progranulin Programs

Leading scientific and clinical experts to provide perspectives and rationale for TREM2 and progranulin targets on December 7 and December 13, respectivelySOUTH SAN FRANCISCO, Nov. 28, 2023 (GLOBE NEWSWIRE) Alector, Inc. (Nasdaq: ALEC), a clinical-stage biotechnology company pioneering immuno-neurology, today announced management will host two virtual events in December to discuss the Company’s TREM2 and progranulin (PGRN) programs. The events will include presentations from Alector’s managem ....

United States , South San Francisco , San Francisco , University Of Massachusetts , Katie Hogan , Laura Perry , Reisa Sperling , Dan Budwick , Michael Heneka , University Of California , Department Of Neurology , Alector Inc , Alzheimer Research , Weill Institute For Cell , Exchange Commission , Department Of Molecular Biology , Luxembourg Centre For Systems Biomedicine , Professor Of Neurology At Harvard Medical School , University Of Luxembourg , University Of Massachusetts Chan Medical School , Molecular Biology At Cornell University , A Pivotal Stage Program For Frontotemporal Dementia , Therapeutic Target , Eastern Standard Time , Luxembourg Centre , Systems Biomedicine ,

Mark Sundrud, PhD: Bile Acid and T Cell Interplay in Cholestatic Diseases

We sat down with Mark Sundrud, PhD, to discuss bile acids and T cells in cholestatic liver disease and the future of research regarding the interplay between intestinal and liver functions. ....

United States , Mark Sundrud , Geisel School Of Medicine At Dartmouth College , Geisel School , Dartmouth College , Gut Liver Axis , Therapeutic Target , Cholestatic Liver , Liver Meeting , American Association , Liver Diseases , T Cell , Bile Acid , Cholestatic Liver Disease ,

Blocking Notch Signalling Lessens Age Related Bone Loss

A cellular signal essential to the development and repair of the skeleton increases abnormally during aging to weaken bones. The study found that blocking this pathway in aging skeletal stem cells caused a “massive increase” in bone mass. ....

Philipp Leucht , Notch Signaling Impacts Bone Health , Langone Health , Bone Research , Grossman School Of Medicine , Department Of Orthopedic Surgery , Technology Network , Signaling Impacts Bone Health , Bone Mass , Therapeutic Target , While Notch , Raj Sobti Menon Associate Professor , Orthopedic Surgery , Lindsey Remark ,